Home LiteratureArticle Details
PMID: 5302327 Published · ppublish English Journal Article

A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.

Bulletin of the World Health Organization ·Vol. 38 ·No. 3 ·1968-00-00 ·Pages 327-34

Mosley WH, Benenson AS, Barui R

Abstract

Controlled cholera vaccine field trials were held in Matlab Bazar in rural East Pakistan in 1963 and 1964. In July-September 1965, a serological survey for cholera antibodies was carried out on a random sample of the field-trial population. Results are given for the control group only, as representative of the pattern found in an endemic cholera area. Only 2% of the blood samples from children under 10 years of age were found to have detectable agglutinating antibody (titres of 1:20 or more), while the proportion in the age-group over 30 years was 27%-30%. Tests for vibriocidal antibody showed that none of the blood samples from children under 1 year of age contained detectable antibody, while 87%-90% of those from adults over 30 years did so. The rise in the geometric mean vibriocidal titre showed an almost linear correlation with a sharp fall in the cholera case rate with age. Since a similar survey in a non-endemic area (Czechoslovakia) did not reveal any rise in antibody titre with age, and since cholera epidemics in areas without recent experience of the disease are characterized by a higher incidence rate in adults than in children, it is suggested that the antibody titres give a measure of the level of immunity in a population.

MeSH Terms
Adolescent Adult Age Factors Agglutination Tests Antibodies/analysis Child Child, Preschool Cholera/epidemiology,immunology Disease Outbreaks Female Humans Infant Infant, Newborn Male Pakistan Rural Health Vaccination
Chemicals
Antibodies
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Mosley W H
Benenson A S
Barui R
References (8)
8 references, click to expand
  1. Studies of cholera El Tor in the Philippines. I. Characteristics of cholera El Tor in Negros Occidental Province, November 1961 to September 1962.
    Bull World Health Organ. 1965;33(5):627-36 PMID: 5295143
  2. Clinical and bacteriological findings among families of cholera patients.
    Lancet. 1966 Feb 12;1(7433):340-2 PMID: 4159477
  3. Serological studies in cholera. I. Vibrio agglutinin response of cholera patients determined by a microtechnique.
    Bull World Health Organ. 1968;38(2):267-76 PMID: 5302302
  4. Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.
    Bull World Health Organ. 1968;38(2):277-85 PMID: 5302303
  5. Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field.
    Bull World Health Organ. 1968;38(3):359-72 PMID: 5302329
  6. A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate.
    Bull World Health Organ. 1968;38(3):335-46 PMID: 5302923
  7. A RECENT STUDY OF CHOLERA WITH REFERENCE TO AN OUTBREAK IN TAIWAN IN 1962.
    Bull World Health Organ. 1964;30:811-25 PMID: 14215187
  8. FIELD TRIAL OF CHOLERA VACCINE IN RURAL EAST PAKISTAN. FIRST YEAR OF OBSERVATION.
    Lancet. 1965 Feb 27;1(7383):450-2 PMID: 14241882
Article Info
Journal
Bulletin of the World Health Organization
Abbr.
Bull World Health Organ
ISSN
0042-9686
Published
1968-00-00
Pages
327-34
Language
English
Region
Switzerland
NLM ID
7507052
PMCID
PMC2554484
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]